Clinical trial

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer…

NCT01570998 · University of California, San Francisco, Other · Active, not recruiting

Key facts

NCT number NCT01570998
Title Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
Official title Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery
Lead sponsor University of California, San Francisco, Other
Collaborators Carl Zeiss Meditec AG Industry
Status Active, not recruiting
Study type Interventional
Conditions Stage IA Breast Cancer, Stage IIA Breast Cancer
Intervention type Other, Radiation
Interventions Intraoperative Radiation Therapy, Laboratory Biomarker Analysis
Enrollment 1,259
Start date May 18, 2012
Primary completion Dec 31, 2028
Completion Dec 31, 2028
First posted Apr 4, 2012
Last update posted Feb 5, 2025
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies